Pricing
Login
Home
Charts
Search
Watchlist
Products

Jagsonpal Pharmaceuticals Ltd

JAGSNPHARM
₹209.27-0.55%20 Nov 2026
Reports
Pharma Formulations

Jagsonpal Pharmaceuticals Ltd

JAGSNPHARM
₹209.27
-0.55%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,382Cr
Close
Close Price
₹209.27
Industry
Industry
Pharma Formulations
PE
Price To Earnings
30.64
PS
Price To Sales
4.60
Revenue
Revenue
₹301Cr
Rev Gr TTM
Revenue Growth TTM
6.40%
PAT Gr TTM
PAT Growth TTM
-26.56%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
474361757459767473648281
Growth YoY
Revenue Growth YoY%
-21.5-21.62.129.156.734.623.1-0.3-1.59.68.89.3
Expenses
ExpensesCr
444151585850615857536565
Operating Profit
Operating ProfitCr
331016169141616111717
OPM
OPM%
7.26.116.721.821.414.918.822.122.317.421.020.6
Other Income
Other IncomeCr
32-22263331332
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
001222222222
PBT
PBTCr
55715399141715121817
Tax
TaxCr
112472444344
PAT
PATCr
4451132711131191313
Growth YoY
PAT Growth YoY%
-49.2-36.6-28.753.4707.885.3102.69.7-65.833.122.10.2
NPM
NPM%
8.48.28.715.343.211.214.316.915.013.616.015.5
EPS
EPS₹
0.60.50.80.71.91.01.61.91.71.32.01.9
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
474361757459767473648281
Growth YoY
Revenue Growth YoY%
-21.5-21.62.129.156.734.623.1-0.3-1.59.68.89.3
Expenses
ExpensesCr
444151585850615857536565
Operating Profit
Operating ProfitCr
331016169141616111717
OPM
OPM%
7.26.116.721.821.414.918.822.122.317.421.020.6
Other Income
Other IncomeCr
32-22263331332
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
001222222222
PBT
PBTCr
55715399141715121817
Tax
TaxCr
112472444344
PAT
PATCr
4451132711131191313
Growth YoY
PAT Growth YoY%
-49.2-36.6-28.753.4707.885.3102.69.7-65.833.122.10.2
NPM
NPM%
8.48.28.715.343.211.214.316.915.013.616.015.5
EPS
EPS₹
0.60.50.80.71.91.01.61.91.71.32.01.9

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
143144127167159188218237209269287301
Growth
Revenue Growth%
3.90.3-12.131.8-5.018.515.88.8-11.828.86.96.4
Expenses
ExpensesCr
132138138157150169193203186218229239
Operating Profit
Operating ProfitCr
126-119919253423515861
OPM
OPM%
8.24.0-8.85.65.410.211.514.411.119.020.220.4
Other Income
Other IncomeCr
113013432928109
Interest Expense
Interest ExpenseCr
531111001111
Depreciation
DepreciationCr
320111212899
PBT
PBTCr
414-129922273530705861
Tax
TaxCr
130225887151415
PAT
PATCr
312-127817192722554345
Growth
PAT Growth%
177.9264.6-197.3162.59.1116.710.541.7-15.9146.4-22.2-26.6
NPM
NPM%
2.38.3-9.14.35.09.18.711.310.820.615.015.1
EPS
EPS₹
0.51.8-1.81.11.22.62.94.13.48.36.46.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
143144127167159188218237209269287301
Growth
Revenue Growth%
3.90.3-12.131.8-5.018.515.88.8-11.828.86.96.4
Expenses
ExpensesCr
132138138157150169193203186218229239
Operating Profit
Operating ProfitCr
126-119919253423515861
OPM
OPM%
8.24.0-8.85.65.410.211.514.411.119.020.220.4
Other Income
Other IncomeCr
113013432928109
Interest Expense
Interest ExpenseCr
531111001111
Depreciation
DepreciationCr
320111212899
PBT
PBTCr
414-129922273530705861
Tax
TaxCr
130225887151415
PAT
PATCr
312-127817192722554345
Growth
PAT Growth%
177.9264.6-197.3162.59.1116.710.541.7-15.9146.4-22.2-26.6
NPM
NPM%
2.38.3-9.14.35.09.18.711.310.820.615.015.1
EPS
EPS₹
0.51.8-1.81.11.22.62.94.13.48.36.46.8
Sales CAGR
1 Year7%
3 Years7%
5 Years9%
TTM6%
EBITDA CAGR
1 Year14%
3 Years19%
5 Years25%
TTM11%
PAT CAGR
1 Year-22%
3 Years17%
5 Years20%
TTM-27%
Avg. ROCE
1 Year21%
3 Years22%
5 Years21%
TTM25%
CFO / EBITDA
1 Year81%
3 Years104%
5 Years100%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
131313131313131313131313
Reserves
ReservesCr
8597859198109120146174226261231
Current Liabilities
Current LiabilitiesCr
572929283340272819262840
Non Current Liabilities
Non Current LiabilitiesCr
4333324811121212
Total Liabilities
Total LiabilitiesCr
159143130136147164164195217278317295
Current Assets
Current AssetsCr
101110959895120109165197161143166
Non Current Assets
Non Current AssetsCr
583335385244553020117174130
Total Assets
Total AssetsCr
159143130136147164164195217278317295
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
131313131313131313131313
Reserves
ReservesCr
8597859198109120146174226261231
Current Liabilities
Current LiabilitiesCr
572929283340272819262840
Non Current Liabilities
Non Current LiabilitiesCr
4333324811121212
Total Liabilities
Total LiabilitiesCr
159143130136147164164195217278317295
Current Assets
Current AssetsCr
101110959895120109165197161143166
Non Current Assets
Non Current AssetsCr
583335385244553020117174130
Total Assets
Total AssetsCr
159143130136147164164195217278317295

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
9-3-2311128747355547
Investing Cash Flow
Investing Cash FlowCr
-241-3-1-11-2-26-58-25-45-36
Financing Cash Flow
Financing Cash FlowCr
-6-34-1-6-1-7-180-9-12-12
Net Cash Flow
Net Cash FlowCr
15-624019-36-112-2-1
Free Cash Flow
Free Cash FlowCr
940-1321428648359047
CFO To PAT
CFO To PAT%
277.8-27.313.6428.2142.9165.436.7174.6156.699.5108.7
CFO To EBITDA
CFO To EBITDA%
76.5-56.214.2331.0131.8147.927.6136.6152.4107.980.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
9-3-2311128747355547
Investing Cash Flow
Investing Cash FlowCr
-241-3-1-11-2-26-58-25-45-36
Financing Cash Flow
Financing Cash FlowCr
-6-34-1-6-1-7-180-9-12-12
Net Cash Flow
Net Cash FlowCr
15-624019-36-112-2-1
Free Cash Flow
Free Cash FlowCr
940-1321428648359047
CFO To PAT
CFO To PAT%
277.8-27.313.6428.2142.9165.436.7174.6156.699.5108.7
CFO To EBITDA
CFO To EBITDA%
76.5-56.214.2331.0131.8147.927.6136.6152.4107.980.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
861007069462088227597431,4341,2341,382
Price To Earnings
Price To Earnings
26.88.49.65.812.243.628.432.925.928.730.6
Price To Sales
Price To Sales
0.60.70.60.40.31.13.83.23.65.34.34.6
Price To Book
Price To Book
0.91.00.80.70.41.86.24.84.06.04.55.7
EV To EBITDA
EV To EBITDA
9.215.2-5.83.71.48.131.819.126.225.719.620.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
56.056.650.255.063.956.558.860.861.564.063.563.5
OPM
OPM%
8.24.0-8.85.65.410.211.514.411.119.020.220.4
NPM
NPM%
2.38.3-9.14.35.09.18.711.310.820.615.015.1
ROCE
ROCE%
6.814.5-10.39.08.617.420.321.415.628.520.725.4
ROE
ROE%
3.310.8-11.86.97.114.014.216.812.023.115.718.7
ROA
ROA%
2.08.3-8.95.35.410.411.513.710.319.913.615.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
861007069462088227597431,4341,2341,382
Price To Earnings
Price To Earnings
26.88.49.65.812.243.628.432.925.928.730.6
Price To Sales
Price To Sales
0.60.70.60.40.31.13.83.23.65.34.34.6
Price To Book
Price To Book
0.91.00.80.70.41.86.24.84.06.04.55.7
EV To EBITDA
EV To EBITDA
9.215.2-5.83.71.48.131.819.126.225.719.620.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
56.056.650.255.063.956.558.860.861.564.063.563.5
OPM
OPM%
8.24.0-8.85.65.410.211.514.411.119.020.220.4
NPM
NPM%
2.38.3-9.14.35.09.18.711.310.820.615.015.1
ROCE
ROCE%
6.814.5-10.39.08.617.420.321.415.628.520.725.4
ROE
ROE%
3.310.8-11.86.97.114.014.216.812.023.115.718.7
ROA
ROA%
2.08.3-8.95.35.410.411.513.710.319.913.615.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,5931,4821,4031,3821,1121,0791,025
Close PriceClose₹2,312.00512.65584.85209.27469.95320.15511.90
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE25.8724.4330.6496.7052.8310.58
Price To SalesPS4.042.803.654.607.181.641.42
RevenueRevenueCr395529385301155656722
Revenue Growth TTMRev Gr TTM%10.6%12.6%38.4%6.4%8.7%14.3%14.3%
PAT Growth TTMPAT Gr TTM%64.3%1.0%64.2%-26.6%31.4%-55.0%21.1%
Market CapitalizationMkt CapCr1,5931,4821,4031,3821,1121,0791,025
Close PriceClose₹2,312.00512.65584.85209.27469.95320.15511.90
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE25.8724.4330.6496.7052.8310.58
Price To SalesPS4.042.803.654.607.181.641.42
RevenueRevenueCr395529385301155656722
Revenue Growth TTMRev Gr TTM%10.6%12.6%38.4%6.4%8.7%14.3%14.3%
PAT Growth TTMPAT Gr TTM%64.3%1.0%64.2%-26.6%31.4%-55.0%21.1%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Jun 24
ResultPPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Jun 24
ResultPPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews